Recent studies on retatrutide, a dual stimulant for glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, demonstrate significant outcomes in treating weight gain and type 2 diabetic condition. Initial information from clinical assessments show notable diminutions in body weig